A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza

Journal of Medical Microbiology

Volumn 56, Issue 7, 2007, Pages 875-883

  Carter, Marissa J ^a  

^a Strategic Solutions Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BUDESONIDE; CORTICOTROPIN; CYTOKINE; DEXAMETHASONE; FLUTICASONE; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; LEVOFLOXACIN; METHYLPREDNISOLONE; OSELTAMIVIR; RIBAVIRIN; SIALIDASE INHIBITOR; STEROID; SULPERAZON;

ADRENAL INSUFFICIENCY; AMINO ACID SEQUENCE; AVIAN INFLUENZA; DRUG MEGADOSE; HONG KONG; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INDONESIA; INFLUENZA VIRUS A H5N1; MONOTHERAPY; MORTALITY; MULTIPLE ORGAN FAILURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SEPSIS; SEVERE ACUTE RESPIRATORY SYNDROME; SHOCK; STEROID THERAPY; SYSTEMATIC REVIEW; THAILAND; VIET NAM;

ADRENAL CORTEX HORMONES; ADRENAL INSUFFICIENCY; AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; RATS;

EID: 34447260688     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47124-0     Document Type: Review

References (70)

1. Ali, M., Allen, H. R., Vedeckis, W. V. & Lang, C. H. (1991). Depletion of rat liver glucocorticoid receptor hormone-binding and its mRNA in sepsis. Life Sci 48, 603-611.
2. Annane, D., Sebille, V., Troche, G., Raphael, J. C., Gajdos, G. & Bellisant, E. (2000). A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 283, 1038-1045.
3. Annane, D., Bellissant, E., Bollaert, P. E., Briegel, J., Keh, D. & Kupfer, Y. (2004). Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 329, 480.
4. Bateman, A., Singh, A., Kral, T. & Solomon, S. (1989). The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 10, 92-112.
5. Beigel, J. H., Farrar, J., Han, A. M., Hayden, F. G., Hyer, R., de Jong, M. D., Lochindarat, S., Tien, N. T. K., Hein, N. T. & other authors (2005). Avian influenza A (H5N1) infection in humans. N Engl J Med 353, 1374-1385.
6. Bernard, G. (2002). The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock. Crit Care 6, 384-386.
7. Besedovsky, H. O. & del Ray, A. (1996). Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17, 64-102.
8. Chadda, K. & Annane, D. (2002). The use of corticosteroids in severe sepsis and acute respiratory distress syndrome. Ann Med 34, 582-589.
9. Chan, M. C. W., Cheung, C. Y., Chui, W. H., Tsao, S. W., Nicholls, J. M., Chan, Y. O., Chan, R. W. Y., Long, H. T., Poon, L. L. M. & other authors (2005). Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6, 135.
10. Chokephaibulkit, K., Uiprasertkul, M., Puthavathana, P., Chearskul, P., Auewarakul, P., Dowell, S. F. & Vanprapar, N. (2005). A child with avian influenza A (H5N1) infection. Pediatr Infect Dis J 24, 162-166.
11. Chotpitayasunondh, T., Ungchusak, K., Hanshaoworakul, W., Chunsuthiwat, S., Sawanpanyalert, P., Kijphati, R., Lochindarat, S., Srisan, P., Suwan, P. & other authors (2005). Human disease from influenza A (H5N1), Thailand. Emerg Infect Dis 11, 201-209.
12. Cutolo, M., Sulli, A., Pizzorni, C., Secchi, M. E., Soldano, S., Seriolo, B., Starub, R. H., Otsa, K. & Maestroni, G. J. (2006). Circadian rhythms: glucocorticoids and arthritis. Ann N Y Acad Sci 1069, 289-299.
13. de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Chau, N. V. V., Khanh, T. H. & other authors (2006). Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12, 1203-1207.
14. Fedson, D. S. (2006). Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin Infect Dis 43, 199-205.
15. Fernandez-Sesma, A., Marukian, S., Ebersole, B. J., Kaminski, D., Park, M. S., Yuen, T., Sealfon, S. C., Garcia-Sastre, A. & Moran, T. M. (2006). Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol 80, 6295-6304.
16. Gaillard, R. C., Turnill, D., Sappino, P. & Muller, A. F. (1990). Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology 127, 101-106.
17. Garcia-Sastre, A. (2006). Antiviral response in pandemic influenza viruses. Emerg Infect Dis 12, 44-47.
18. Gomersall, C. D., Kargel, M. J. & Lapinsky, S. E. (2004). Pro/con clinical debate: steroids are a key component in the treatment of SARS. Crit Care 8, 105-107.
19. Guo, J. Y., Huo, H. R., Zhao, B. S., Liu, H. B., Li, L. F., Ma, Y. Y., Guo, S. Y. & Jiang, T. L. (2006). Cinnamaldehyde reduces Il-1 β-induced cycloxygenase activity in rat cerebral microvascular endothelial cells. Eur J Pharmacol 537, 174-180.
20. Hien, T. T., Liem, N.T., Dung, N. T., San, L. T., Mai, P. P., van Vinh Chau, N., Suu, P. T., Dong, V. C., Mai, L. T. Q. & other authors (2004). Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 350, 1179-1188.
21. Hsieh, S. M. & Chang, S. C. (2006). Cutting edge: insufficient perforin expression in CD8+ T cells in response to hemagglutinin from avian influenza (H5N1) virus. J Immunol 176, 4530-4533.
22. Hussell, T., Pennycook, A. & Openshaw, P. J. (2001). Inhibition of tumor necrosis factor reduces the severity of virus-lung immunopathology. Eur J Immunol 31, 2566-2573.
23. Jaattela, M., Carpen, O., Stenman, U. H. & Saksela, E. (1990). Regulation of ACTH-induced steroidogenesis in human fetal adrenals by rTNF-α. Mol Cell Endocrinol 68, R31-R36.
24. Jaattela, M., Ilvesmaki, V., Voutilainen, R., Stenman, U. H. & Saksela, E. (1991). Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 128, 623-629.
25. Jefferies, W. M., Turner, J. C., Lobo, M. & Gwaltney, J. M., Jr (1998). Low plasma levels of adrenocorticotropin hormone in patients with acute influenza. Clin Infect Dis 26, 708-710.
26. Kandun, I. N., Wibisono, H., Sedyaningsih, E. R., Yusharmen, D. P. H., Hadisoedarsuno, W., Purba, W., Santoso, H., Septiawati, C., Tresnaningsih, E. & other authors (2006). Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 355, 2186-2194.
27. Kash, J. C., Basler, C. F., Garcia-Sastre, A., Carter, V., Billharz, R., Swayne, D. E., Przygodzki, R. M., Taubenberger, J. K., Katze, M. G. & Tumpey, T. M. (2004). Global host immune response: pathogenesis and transcriptional profiling of type A influenza expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. J Virol 78, 9499-9511.
28. Kennedy, M. J., Carpenter, J. M., Lozano, R. A. & Castile, R. G. (2002). Impaired recovery of hypothalamic-pituitary-adrenal axis function and hypoglycemic seizures after high-dose inhaled corticosteroid therapy in a toddler. Ann Allergy Asthma Immunol 88, 523-526.
29. Konstantinos, A. P. & Sheridan, J. F. (2001). Stress and influenza viral infection: modulation of proinflammatory cytokine responses in the lung. Respir Physiol 128, 71-77.
30. Lee, D. C. W., Cheung, C. Y., Law, A. H. Y., Mok, C. K. P., Peiris, M. & Lau, A. S. Y. (2005). p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor α expression in response to avian influenza virus H5N1. J Virol 79, 10147-10154.
31. Li, Y. M., Wang, S. X., Gao, H. S., Wang, J. G., Wei, C. S., Chen, L. M., Hui, W. L., Yuan, S. L., Jiao, Z. S. & other authors (2004). Factors of avascular necrosis of femoral head and osteoporosis in SARS patient' convalescence. Zhonghua Yi Xue Za Zhi 84, 1348-1353 (in Chinese).
32. Liu, B., Mori, I., Hossian, M. J., Dong, L., Takeda, K. & Kimura, Y. (2004). Interleukin-18 improves the early defence system against influenza infection by augmenting natural killer cell-mediated cytotoxicity. J Gen Virol 85, 423-428.
33. Loutfy, M. R., Blatt, L. M., Siminovitch, K. A., Ward, S., Wolff, B., Lho, H., Pham, D. H., Deif, H., LaMere, E. A. & other authors (2003). Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 290, 3222-3228.
34. Marik, P. E. & Zaloga, G. P. (2002). Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 122, 1784-1796.
35. Mastorakos, G., Chrousos, G. P. & Weber, J. S. (1993). Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77, 1690-1694.
36. Matikainen, S., Siren, J., Tissari, J., Veckman, V., Pirhonen, J., Severa, M., Sun, Q., Lin, R., Meri, S. & other authors (2006). Tumor necrosis factor α enhances influenza virus-induced expression of antiviral cytokines by activating RIG-I expression. J Virol 80, 3515-3522.
37. Meduri, G. U. & Chrousos, G. P. (1998). Duration of glucocorticoid treatment and outcome in sepsis: is the right drug used in the wrong way? Chest 114, 355-360.
38. Meduri, G. U. & Yates, C. R. (2004). Systematic inflammation-associated glucocorticoid resistance and outcome of ARDS. Ann N Y Acad Sci 1024, 24-53.
39. Molijn, G. J., Koper, J. W., van Uffelen, C. J., de Jong, F. H., Brinkmann, A. O., Bruining, H. A. & Lamberts, S. W. (1995). Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock. Clin Endocrinol (Oxf) 43, 197-203.
40. Moscona, A. (2005). Neuraminidase inhibitors for influenza. N Engl J Med 353, 1363-1373.
41. Ng, P. C., Lam, C. W., Li, A. M., Wong, C. K., Cheng, F. W., Leung, T. F., Hon, E. K., Chan, I. H., Li, C. K. & other authors (2004). Inflammatory cytokine profile in children with severe acute respiratory syndrome. Pediatrics 113, e7-e14.
42. Ng, W. F., To, K. F., Lam, W. W., Ng, T. K. & Lee, K. C. (2006). The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1 - a review. Hum Pathol 37, 381-390.
43. Nunoi, H., Mercado, M. R., Mizukami, T., Okajima, K., Morishima, T., Sakata, H., Nakayama, S., Mori, S., Hayashi, M. & other authors (2005). Apoptosis under hypercytokinemia is a possible pathogenesis in influenza-associated encephalopathy. Pediatr Int 47, 175-179.
44. Onoguchi, K., Yoneyama, M., Takemura, A., Akira, S., Taniguchi, T., Namiki, H. & Fujita, T. (2007). Viral infections activate type I and type III interferon genes through a common mechanism. J Biol Chem 282, 7576-7581.
45. Osterholm, M. T. (2005). Preparing for the next flu pandemic. N Engl J Med 352, 1839-1842.
46. Ottolini, M., Blanco, J., Porter, D., Peterson, L., Curtis, S. & Prince, G. (2003). Combination of anti-inflammatory and antiviral therapy of influenza in a cotton rat model. Pediatr Pulmonol 36, 290-294.
47. Ottolini, M. G., Blanco, J. C. G., Eichelberger, M. C., Porter, D. D., Pletneva, L., Richardson, J. Y. & Prince, G. A. (2005). The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis. J Gen Virol 86, 2823-2830.
48. Padgett, D. A., Loria, R. M. & Sheridan, J. F. (2000). Steroid hormone regulation of antiviral immunity. Ann N Y Acad Sci 917, 935-943.
49. Palucka, A. K., Blanck, J. P., Bennett, L., Pascual, V. & Banchereau, J. (2005). Cross-regulation of TNF and IFN-α in autoimmune diseases. Proc Natl Acad Sci USA 102, 3372-3377.
50. Pawliczak, R., Logun, C., Madara, P., Barb, J., Suffredini, A. F., Munson, P. J., Danner, R. L. & Shelhamer, J. H. (2005). Influence of IFN-γ on gene expression in normal bronchial epithelial cells: modulation of IFN-γ effects by dexamethasone. Physiol Genomics 23, 28-45.
51. Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D., Green, K., Tellier, R., Draker, R., Adachi, D. & other authors (2003). Identification of severe acute respiratory syndrome in Canada. N Engl J Med 348, 1995-2005.
52. Pretorius, E., Wallner, B. & Marx, J. (2006). Cortisol resistance in conditions such as asthma and the involvement of 11-β-HSD-2: a hypothesis. Horm Metab Res 38, 368-376.
53. Rainsford, K. D. (2006). Influenza ('Bird Flu'), inflammation, and anti-inflammatory/analgesic drugs. Inflammopharmacology 14, 2-9.
54. Reily, M. M., Pantoja, C., Hu, X., Chinenov, Y. & Rogatsky, I. (2006). The GRIP : IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J 25, 108-117.
55. Rio, J., Nos, C., Marzo, M. E., Tintore, M. & Montalban, X. (1998). Low-dose steroids reduce flu-like symptoms at the initiation of IFNbeta-lb in relapsing-remitting MS. Neurology 50, 1910-1912.
56. Samuels, M. H. (2000). Effects of variations in physiological cortisol levels on thyrotropin secretion in subjects with adrenal insufficiency: a clinical research center study. J Clin Endocrinol Metab 85, 1388-1393.
57. Sareneva, T., Matikainen, S., Kurimoto, M. & Julkunen, I. (1998). Influenza A virus-induced IFN-αβ and Il-18 synergistically enhance IFN-γ expression in human T cells. J Immunol 160, 6032-6038.
58. Sladkova, T. & Kostolansky, F. (2006). The role of cytokines in the immune response to influenza A virus infection. Acta Virol 50, 151-162.
59. Stockman, L. J., Bellamy, R. & Garner, P. (2006). SARS: systematic review of treatment effects. PLoS Med 3, e343.
60. Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D. & Panoskaltsis, N. (2006). Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355, 1018-1028.
61. Suzuki, F., Oya, J. & Ishida, N. (1974). Effect of antilymphocyte serum on influenza virus infection in mice. Proc Soc Exp Biol Med 146, 78-84.
62. To, K. F., Chan, P. K., Chan, K. F., Lee, W. K., Lam, W. Y., Wong, K. F., Tang, N. L., Tsang, D. N., Sung, R. Y. & other authors (2001). Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 63, 242-246.
63. Uiprasertkul, M., Puthavathana, P., Sangsiriwut, K., Pooruk, P., Srisook, K., Peiris, M., Nicholls, J. M., Chokephaibulkit, K., Vanprapar, N. & Auewarakul, P. (2005). Influenza A H5N1 replication sites in humans. Emerg Infect Dis 11, 1036-1041.
64. Webster, R. G. & Govorkova, E. A. (2006). H5N1 influenza - continuing evolution and spread. N Engl J Med 355, 2174-2177.
65. Wei, L., Sandbulte, M. R., Thomas, P. G., Webby, R. J., Homayouni, R. & Pfeffer, R. M. (2006). NFκB negatively regulates interferon-induced gene expression and anti-influenza activity. J Biol Chem 281, 11678-11684.
66. Wheatland, R. (2004). Molecular mimicry of ACTH in SARS - implications for corticosteroid treatment and prophylaxis. Med Hypotheses 63, 855-862.
67. World Health Organization (WHO) (2005). Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis 11, 1515-1521.
68. Yuen, K. Y. & Wong, S. S. Y. (2005). Human infection by avian influenza A H5N1. Hong Kong Med J 11, 189-199.
69. Yuen, K. Y., Chan, P. K. S., Peiris, M., Tsang, D. N. C., Que, T. L., Shortridge, K. F., Cheung, P. T., To, W. K., Ho, E. T. F. & other authors (1998). Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351, 467-471.
70. Zhao, Z., Zhang, F., Xu, M., Huang, K., Zhong, W., Cai, W., Yin, Z., Huang, S., Deng, Z. & other authors (2003). Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 52, 715-720.